[Prevention of bioterrorism by vaccines]

Area of Science:

• Biodefense and Public Health
• Infectious Disease Research
• Vaccinology

Context:

• Bioterrorism presents a significant threat due to the wide array of potential biological agents.
• Existing countermeasures, such as the classical smallpox vaccine, pose safety concerns.
• The development of effective vaccines and therapies for emerging infectious diseases is a global priority.

Purpose:

• To review the challenges and necessities in developing countermeasures against bioterrorism agents.
• To highlight the need for safer vaccine alternatives and novel therapeutic strategies.
• To emphasize the urgency of research into protection against diverse biological threats.

Summary:

• The multiplicity of potential bioterrorism agents complicates prevention efforts.
• Safer vaccines are needed for smallpox, and progress is anticipated for anthrax.
• Research on plague, viral hemorrhagic fevers, and antibody-based therapies for botulism and resistant bacteria is critical.

Impact:

• Enhancing global biodefense capabilities through improved vaccine and therapeutic development.
• Reducing public health risks associated with bioterrorism threats.
• Accelerating research and development for novel medical countermeasures against biological agents.